Trial Information
Women At Risk: The High Risk Breast Cancer Program
This is a longitudinal cohort study that collects data of eligible women at risk for
developing breast cancer. Patient information will be entered into a secured computerized
database that is used for research on the prevention, early detection and treatment of
breast cancer.
Inclusion Criteria:
- one or more first-degree relatives (mother, daughter, or sister) with pre-menopausal
breast cancer
- two or more first-degree relatives with post-menopausal breast cancer
- tested positive for a BRCA1 or BRCA2 mutation
- a history of biopsy-proven atypical ductal hyperplasia or atypical lobular
hyperplasia
- a history of biopsy-proven lobular neoplasia (lobular carcinoma in situ)
Exclusion Criteria:
- DCIS (ductal carcinoma in situ)
- previous diagnosis of breast cancer
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Principal Investigator
Kathie-Ann Joseph, MD, MPH
Investigator Role:
Principal Investigator
Investigator Affiliation:
Columbia University/New York Presbyterian Hospital
Authority:
United States: Institutional Review Board
Study ID:
AAAA4649
NCT ID:
NCT01034891
Start Date:
January 1991
Completion Date:
Related Keywords:
- Breast Cancer
- BRCA mutation
- benign breast disease
- family history of breast cancer
- strong family history of breast cancer
- atypical ductal hyperplasia
- atypical lobular hyperplasia
- high risk for breast cancer
- Breast Neoplasms
Name | Location |
Women At Risk, Columbia University Medical Center |
New York, New York 10032 |
Women At Risk, Weill Cornell |
New York, New York 10065 |